Global X S&P Biotech ETF (ASX:CURE)
Australia · Delayed Price · Currency is AUD 62.00
-0.94 (-1.49%)
At close: Dec 31, 2025
ASX:CURE Holdings Information
ASX:CURE is an equity ETF with a total of 10 individual holdings. The top holdings are Amicus Therapeutics stock at 1.47%, Praxis Precision Medicines at 1.42%, Travere Therapeutics at 1.38%, BioMarin Pharmaceutical at 1.36%, and Exelixis at 1.35%.
Total Holdings
10
Top 10 Percentage
13.57%
Asset Class
Equity
ETF Category
Health Care
Assets
42.85M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | FOLD | Amicus Therapeutics, Inc. | 1.47% |
| 2 | PRAX | Praxis Precision Medicines, Inc. | 1.42% |
| 3 | TVTX | Travere Therapeutics, Inc. | 1.38% |
| 4 | BMRN | BioMarin Pharmaceutical Inc. | 1.36% |
| 5 | EXEL | Exelixis, Inc. | 1.35% |
| 6 | HALO | Halozyme Therapeutics, Inc. | 1.34% |
| 7 | RYTM | Rhythm Pharmaceuticals, Inc. | 1.31% |
| 8 | REGN | Regeneron Pharmaceuticals, Inc. | 1.31% |
| 9 | MRNA | Moderna, Inc. | 1.31% |
| 10 | ROIV | Roivant Sciences Ltd. | 1.31% |
As of Dec 30, 2025